Aquisição medicamentos anifrolumab inj.conc.perf. 150mg/ml 2ml iv _ tezepelumab caneta 210mg 110mg/ml 1.91ml sc_zirconio 10g; po susp.oral saq; zirconio 5g po susp.oral saq.

ID 11316240 · Portal BASE
Price
Base Price
€182,732 .00
Effective Price
€18,732 .00 -89.7%
Contract Details
Contract Type
Aquisição de bens móveis
Procedure
Ajuste Direto Regime Geral
CPV Code
33600000
Location
Portugal, Porto, Porto
Bidder Count
—
Winner
ASTRAZENECA - PRODUTOS FARMACÊUTICOS LDA
NIF 502942240
Company
Dates
Publication
29 Mar 2025
Celebration
29 Jan 2025
Contracting Entity
Unidade Local de Saúde de Santo António, EPE
NIF 517392259
Public body
Data Source
Portal BASE
Api · synced 2026-04-17
Risk Flags
Score 100 · HIGH RISK
A1 · Repeat Direct Award
A1_REPEAT_DIRECT_AWARD
HIGH
Authority
745
Supplier
45
Number of Awards
14
Rule
A1 repeat direct award: 14 awards within 36 months
Detected 2026-03-06
A2 · Late Publication
A2_PUBLICATION_AFTER_CELEBRATION
HIGH
Publication Date
29 Mar 2025
Signing Date
29 Jan 2025
Days Late
59
Rule
A2/A3 late publication: 59 days after signing (threshold: 10)
Detected 2026-03-06
A9 · Abnormal Price Reduction
A9_PRICE_REDUCTION
LOW
Base price
182732.0
Total effective price
18732.0
Ratio
0.1025
Direction
reduction
Rule
A9 price reduction: ratio 0.1025 outside [0.5, 1.5]
Detected 2026-03-06